{"page_content": "Amgen 2017 Responsibility Highlights Report    8OPERATING RESPONSIBLY ENVIRONMENT REPORTING WORKPLACE PATIENTS COMMUNITY COMMITMENT\nCOMMITMENTCOMMITMENT\nDuring 2017, we conducted a \nstakeholder assessment to update and enhance our understanding of the responsibility issues of greatest importance to internal and external stakeholders. We gathered information from stakeholders using direct interviews, online surveys, group discussions and review of relevant published material. We surveyed internal stakeholders to understand their perspectives on issues that impact Amgen\u2019s business. External stakeholders surveyed included patient advocacy organizations, corporate social responsibility-focused non-government organizations, investors and organizations devoted to promoting access to medicine. We are using the information we gained to help shape our approach to programs and reporting as we move forward.\nMost Important Importance to External Stakeholders\nImpact on BusinessEXTERNAL\nENGAGEMENT\nPHILANTHROPY& SCIENCE EDUCATIONHUMANRIGHTSDIVERSITY &\nINEQUALITYPRODUCTS &SUPPLY CHAIN\nINNOVATION& GROWTHSAFE, EFFECTIVEMEDICINEACCESS TO MEDICINEETHICAL BUSINESS\nENVIRONMENT, HEALTH & SAFETY\nMost Impactful\nWhile all issues included in this assessment are important, this graph shows that, in the view of a variety of stakeholders, \nenhancing access to medicine, making safe and effective medicines and conducting business in an ethical manner are currently the highest priority issues. Stakeholder Assessment Results", "metadata": {"source": "NASDAQ_AMGN_2017.pdf", "page": 7, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}